HSCA Applauds Ongoing Bipartisan Efforts that Increase Supply Chain Transparency
The Healthcare Supply Chain Association (HSCA) and its traditional healthcare group purchasing organization (GPO) members applaud the ongoing bipartisan Congressional efforts to increase healthcare supply chain transparency for the ultimate benefit of patients. Specifically, we support two bipartisan drug supply chain transparency measures: the Drug Origin Transparency Act, sponsored by Rep. Doris Matsui (D-CA) and Rep. Dan Crenshaw (R-TX), and the Consumer Labeling for Enhanced API Reporting and Legitimate Accountability for Base Entity Listings (CLEAR LABELS) Act, sponsored by Sens. Rick Scott (R-FL) and Kirsten Gillibrand (D-NY).
“HSCA has long advocated for better visibility into upstream healthcare supply chain information. Increasing transparency, such as providing country-of-origin labeling requirements, will help provide critical visibility for traditional healthcare GPOs, providers, and the patients they serve,” said HSCA President and CEO Angie Boliver. “Tracking and labeling of manufacturing sources would help the FDA and stakeholders across the pharmaceutical supply chain anticipate potential supply disruptions and proactively mitigate the effects of shortages.”
Both bills would require drug labels to include the original manufacturer of the product and the original manufacturer of the active pharmaceutical ingredient, and the Drug Origin Transparency Act would further enable the FDA to require more detailed reporting on API suppliers.
“The Drug Origin Transparency Act and CLEAR LABELS Act are critical steps to help ensure American patients have access to safe and effective medications. HSCA and its member GPOs applaud Rep. Matsui, Sen. Scott, and Sen. Gillibrand for leading this effort, and we look forward to continuing to work with Congress to increase transparency in the pharmaceutical supply chain.”
###
About the Healthcare Supply Chain Association (HSCA)
The Healthcare Supply Chain Association (HSCA) represents the nation’s leading healthcare group purchasing organizations (GPOs), which are critical cost-savings partners to America’s hospitals, nursing homes, nursing home pharmacies, clinics, home healthcare providers, and surgery centers. GPOs deliver billions in savings annually to healthcare providers, Medicare and Medicaid, and taxpayers. HSCA and its member GPOs are committed to delivering the best products at the best value to healthcare providers, increasing competition and innovation in the market, and serving as leaders in transparency and accountability. For more information, visit supplychainassociation.org. Follow HSCA on X (Twitter) @HSCA.
Lear MoreHSCA Response to the U.S. Trade Representative’s Section 301 Investigation of Acts, Policies, and Practices of Certain Economies Relating to Structural Excess Capacity and Production in Manufacturing Sectors
On behalf of the Healthcare Supply Chain Association (HSCA), which represents the nation’s leading traditional healthcare group purchasing organizations (GPOs), we appreciate the opportunity to provide comments to the Office of the U.S. Trade Representative on its Section 301 investigation into structural excess capacity and production in manufacturing sectors.
Click here to view the full response.
Lear MoreHSCA Comments on the Centers for Medicare & Medicaid Services Advance Notice of Proposed Rulemaking on Ensuring Safety Through Domestic Security With Made in America PPE and Essential Medicine Procurement by Medicare Participating Hospitals
On behalf of the Healthcare Supply Chain Association (HSCA), which represents the nation’s leading traditional healthcare group purchasing organizations (GPOs), we appreciate the opportunity to provide comments to the Centers for Medicare and Medicaid Services (CMS) regarding its Advance Notice of Proposed Rulemaking (ANPRM) on Ensuring Safety Through Domestic Security With Made in America Personal Protective Equipment (PPE) and Essential Medicine [CMS-1516-ANPRM].
Click here to view the full response.
Lear MoreTestimony of HSCA CEO Angie Boliver before the Subcommittee on Health, House Committee on Energy and Commerce
Thank you for the opportunity to discuss the important role of traditional healthcare group purchasing organizations (GPOs) in lowering costs in the pharmaceutical supply chain.
Click here to view the full response.
Lear More